Warning letterFDA · Sep 7, 2021
Phytag Labs MARCS-CMS 614514, September 07, 2021
Named company: Phytag Labs
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your GLUCOTYPE2 product fails to bear…
Lot information: not specified in this record.